SeqLL (SQLLW) Stock Price, News & Analysis

Company Overview

SeqLL, Inc. is a life sciences company focused on developing and commercializing a proprietary nanopore-based sequencing platform for long-read DNA and RNA analysis. The company’s technology enables single-molecule detection through ultrathin nanopores, allowing researchers to generate high-resolution sequence data with minimal sample preparation and without the need for amplification.

The company’s flagship offering includes a benchtop sequencing instrument, custom reagents and consumables, and a suite of bioinformatics software designed to streamline data acquisition and analysis. SeqLL’s platform is capable of delivering detailed insights into genetic variation, transcript isoforms and epigenetic modifications, making it suitable for applications in genomics research, transcriptomics and clinical biomarker discovery.

Headquartered in Seattle, Washington, SeqLL serves a broad customer base that includes academic institutions, biotechnology firms and pharmaceutical companies across North America, Europe and Asia. The company’s management team comprises industry veterans with extensive experience in molecular biology, genomics and instrument development, positioning SeqLL to address the growing demand for high-accuracy, long-read sequencing solutions.

Key Stats

• Today's Range: $0.0033 to $0.0033
• 50-Day Range: N/A
• 52-Week Range: $0.0020 to $0.0094
• Volume: N/A
• Average Volume: 35,059 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Consumer Finance
• Sub-Industry: Consumer Finance
• Current Symbol: NASDAQ:SQLLW
• CIK: 1605888
• Web: N/A
• Phone: 781-460-6016
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A